Scleroderma is a rare but potentially life-threatening disabling condition that affects about 50,000 people in the U.S. It is an autoimmune connective tissue disorder in which cells called fibroblasts produce excessive collagen. Although scleroderma was originally thought to be a skin disease, it is now known that the disease not only affects the skin, but also can produce significant microvascular damage and excessive collagen deposits in the musculoskeletal system and internal organs. The most frequent skin manifestation is skin hardening and thickening. The clinical presentation, extent and severity of internal organ involvement and clinical course vary greatly. For some people, hard, tight skin is the extent of the pathological process. For others, scleroderma may become a life-threatening process that affects blood vessels and internal organs.
The goal of this scleroderma continuing education module is to educate healthcare providers about the pathological process, manifestations and treatment options for people with scleroderma. After studying the information presented here, you will be able to:
- Describe three pathological processes involved in scleroderma
- Differentiate between localized and systemic forms of scleroderma
- Describe three scleroderma treatment strategies
This CE course is intended for massage therapists.
OnCourse Learning is approved by the National Certification Board for Therapeutic Massage & Bodywork (NCBTMB) as a continuing education approved provider (prov no. 451980-12 from 06/08/2012 to 12/29/2014, 1183 from 09/02/2016 through 09/02/2019).
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. ContinuingEducation.com guarantees this educational activity is free from bias.
Please see CE Course Instructions to learn how to earn CE credit for this module.